Seeking Alpha

More on Myriad Genetics (MYGN +8.9%): The mixed ruling was not a surprise to many, as the Court...

More on Myriad Genetics (MYGN +8.9%): The mixed ruling was not a surprise to many, as the Court expressed skepticism over whether human DNA extracted from the body could be patented like a mechanical invention during arguments in April. Nevertheless, it removes an overhang for the sector. Read more here: (Supreme Court Ruling).
Comments (2)
  • Whitehawk
    , contributor
    Comments (3129) | Send Message
     
    On the surface, a good ruling. Michael Crichton raising his hand from the grave.
    13 Jun 2013, 01:20 PM Reply Like
  • Phill Stone
    , contributor
    Comments (78) | Send Message
     
    good to know my body is still mine...
    13 Jun 2013, 03:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|